honokiol has been researched along with 4-methoxyhonokiol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Esumi, T; Fukuyama, Y; Makado, G; Mitsumoto, Y; Shimizu, Y; Zhai, H | 1 |
| Bae, KH; Chang, MJ; Chen, QC; Jin, WY; Kim, HJ; Lee, IS; Lee, JP; Min, BS; Youn, UJ | 1 |
| Adams, M; Bauer, R; Bodensieck, A; Haslinger, E; Hüfner, A; Kunert, O; Oluwemimo, A; Pferschy-Wenzig, EM; Prettner, E; Schühly, W | 1 |
| Baburin, I; Ecker, GF; Hering, S; Huefner, A; Schuehly, W; Taferner, B; Wiesner, K | 1 |
| Chen, J; Chen, L; Jie, S; Li, S; Liang, X; Luo, Y; Ma, L; Peng, A; Peng, M; Wang, T; Wang, X; Wei, Y; Zhu, W | 1 |
| Altmann, KH; Anavi-Goffer, S; Gertsch, J; Huefner, A; Kleyer, J; Paredes, JM; Raduner, S; Schuehly, W | 1 |
| Amin, S; Lin, JM; Prakasha Gowda, AS; Sharma, AK | 1 |
| Fuchs, A; Hinz, S; Karcz, T; Koetter, U; Lehr, M; Müller, CE; Rempel, V | 1 |
| Arena, C; Bertini, S; Chicca, A; Chicca, S; Gertsch, J; Macchia, M; Manera, C; Saccomanni, G | 1 |
| Jung, JK; Kim, SY; Lim, D; Seo, SY; Subedi, L; Yuan, Y | 1 |
| Chen, A; Hu, A; Lin, D; Liu, J; Peng, J; Wu, X; Yan, Z; Ye, J | 1 |
| Dai, Y; Huang, X; Li, B; Li, HM; Li, Y; Ma, H; Wang, H; Wu, CZ; Zhu, M | 1 |
| Fan, P; Li, C; Lou, H; Shi, X; Song, H; Zhang, T | 1 |
| Bae, BK; Choi, GJ; Choi, JE; Choi, NH; Choi, YH; Jang, KS; Kang, MS; Kim, JC; Min, BS; Park, MS | 1 |
| Han, HK; Van Anh, LT | 1 |
| Baur, R; Schuehly, W; Sigel, E | 1 |
| Bennett, B; Bui, D; Cheng, G; Feng, L; Hu, M; Kalyanaraman, B; Kim, YH; Myers, CR; Pan, J; Schmainda, K; Shin, SS; Wang, Y; Xiong, D; You, M; Zhang, Q; Zielonka, J | 1 |
17 other study(ies) available for honokiol and 4-methoxyhonokiol
| Article | Year |
|---|---|
Efficient synthesis and structure-activity relationship of honokiol, a neurotrophic biphenyl-type neolignan.
Topics: Animals; Biphenyl Compounds; Cells, Cultured; Cerebral Cortex; Fetus; Lignans; Nerve Growth Factors; Neurites; Neurodegenerative Diseases; Neurons; Rats; Structure-Activity Relationship | 2004 |
Cytotoxic lignans from the stem bark of Magnolia officinalis.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Inhibitory Concentration 50; Korea; Lignans; Magnolia; Molecular Structure; Plant Bark; Plant Stems; Plants, Medicinal | 2007 |
Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
Topics: Arachidonate 5-Lipoxygenase; Biphenyl Compounds; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Humans; Leukocytes; Leukotriene B4; Lignans; Magnolia; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2009 |
Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.
Topics: Animals; Biphenyl Compounds; Lignans; Models, Molecular; Oocytes; Receptors, GABA-A; Structure-Activity Relationship; Xenopus laevis | 2011 |
Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Topics: Allyl Compounds; Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Benzaldehydes; Biphenyl Compounds; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Embryo, Nonmammalian; Endothelial Cells; Endothelium, Vascular; Humans; In Vitro Techniques; Lignans; Magnolia; Neovascularization, Pathologic; Neovascularization, Physiologic; Structure-Activity Relationship; Zebrafish | 2011 |
Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists.
Topics: Animals; Biphenyl Compounds; Calcium; Cannabinoid Receptor Modulators; Cell Line; Cell Migration Inhibition; Cells, Cultured; Cyclic AMP; Humans; Lignans; Macrophages; Mice; Monocytes; Osteoclasts; Osteogenesis; Plant Extracts; Plants; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha | 2011 |
In vitro growth inhibition of human cancer cells by novel honokiol analogs.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50; Lignans; Lung Neoplasms; Molecular Structure; Structure-Activity Relationship | 2012 |
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
Topics: | 2013 |
Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands.
Topics: Animals; Biphenyl Compounds; Chemistry Techniques, Synthetic; CHO Cells; Cricetinae; Cricetulus; Drug Design; Humans; Ligands; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2016 |
Synthesis and anti-neuroinflammatory activity of N-heterocyclic analogs based on natural biphenyl-neolignan honokiol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Biphenyl Compounds; Cell Line; Dose-Response Relationship, Drug; Heterocyclic Compounds; Lignans; Lipopolysaccharides; Mice; Molecular Structure; Nitric Oxide; Structure-Activity Relationship | 2019 |
Anti-proliferative activity and structure-activity relationship of honokiol derivatives.
Topics: Biphenyl Compounds; Humans; Lignans; Structure-Activity Relationship | 2019 |
Synthesis and in vitro antitumor evaluation of honokiol derivatives.
Topics: Antineoplastic Agents; Biphenyl Compounds; Humans; Lignans; Neoplasms | 2020 |
Anticancer Effects of Honokiol via Mitochondrial Dysfunction Are Strongly Enhanced by the Mitochondria-Targeting Carrier Berberine.
Topics: Antineoplastic Agents; Apoptosis; Berberine; Biphenyl Compounds; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lignans; Membrane Potential, Mitochondrial; Mitochondria; Molecular Structure; Reactive Oxygen Species; Structure-Activity Relationship | 2020 |
Effects of neolignans from the stem bark of Magnolia obovata on plant pathogenic fungi.
Topics: Allyl Compounds; Antifungal Agents; Biphenyl Compounds; Chromatography, Thin Layer; Fungi; Lignans; Magnolia; Microbial Sensitivity Tests; Mycelium; Phenyl Ethers; Plant Bark; Plant Diseases; Plant Extracts | 2009 |
Modulation of P-glycoprotein expression by honokiol, magnolol and 4-O-methylhonokiol, the bioactive components of Magnolia officinalis.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Cell Line, Tumor; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lignans; Magnolia; Plant Extracts | 2012 |
Moderate concentrations of 4-O-methylhonokiol potentiate GABAA receptor currents stronger than honokiol.
Topics: Animals; Biphenyl Compounds; GABA-A Receptor Agonists; Gastrointestinal Agents; Humans; Lignans; Magnolia; Membrane Potentials; Plant Bark; Receptors, GABA-A; Xenopus laevis | 2014 |
Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Humans; Lignans; Magnolia; Mice; Mice, Nude; Mitochondria; Mouth Neoplasms; Plant Extracts; Reactive Oxygen Species | 2020 |